Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RY WILLIS BERGUM

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1275103459
CMS profile
11020829
Location
CATAWBA, VA

General Payments · PY2021–2024

$684.44

  • Reported across 17 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$627.28

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $627.28 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $330.00 4
E.R. Squibb & Sons, L.L.C. $162.51 4
ITI, Inc. $49.16 2
ABBVIE INC. $23.00 1
BioXcel Therapeutics, Inc. $22.79 1
Alkermes, Inc. $20.71 1
Indivior Inc. $19.11 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $57.16 3
PY2024 $627.28 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2021 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.00 09/17/2024 Food and Beverage Undisputed 01/23/2026 1106517382 CMS
Alkermes, Inc. $20.71 08/20/2024 Food and Beverage Undisputed 01/23/2026 1120466419 CMS
BioXcel Therapeutics, Inc. $22.79 05/20/2024 Food and Beverage Undisputed 01/23/2026 1150029400 CMS
E.R. Squibb & Sons, L.L.C. $5.16 10/14/2024 Food and Beverage Undisputed 01/23/2026 1101468669 CMS
E.R. Squibb & Sons, L.L.C. $31.80 10/14/2024 Food and Beverage Undisputed 01/23/2026 1101468676 CMS
E.R. Squibb & Sons, L.L.C. $6.25 10/15/2024 Food and Beverage Undisputed 01/23/2026 1101468680 CMS
E.R. Squibb & Sons, L.L.C. $119.30 11/12/2024 Food and Beverage Undisputed 01/23/2026 1101468728 CMS
Indivior Inc. $19.11 07/16/2024 Food and Beverage Undisputed 01/23/2026 1144544251 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.01 01/16/2024 Food and Beverage Undisputed 01/23/2026 1143374961 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.15 04/16/2024 Food and Beverage Undisputed 01/23/2026 1143374964 CMS
Teva Pharmaceuticals USA, Inc. $123.86 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151553878 CMS
Teva Pharmaceuticals USA, Inc. $120.87 06/18/2024 Food and Beverage Undisputed 01/23/2026 1151553912 CMS
Teva Pharmaceuticals USA, Inc. $56.96 09/10/2024 Food and Beverage Undisputed 01/23/2026 1151553972 CMS
Teva Pharmaceuticals USA, Inc. $28.31 11/18/2024 Food and Beverage Undisputed 01/23/2026 1151553992 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.